Cause of death, by non-communicable diseases, ages 5-14, female in Latin America & Caribbean
Latin America & Caribbean: Cause of death, by non-communicable diseases, ages 5-14, female was 47.2% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, female in Latin America & Caribbean, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 5-14.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 5-14, female in Latin America & Caribbean stood at 47.2%.
The figure is down 4.4% on the previous year and up 70.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, female in Latin America & Caribbean peaked at 51.6% in 2019 and was at its lowest, 27.6%, in 2010.
Latin America & Caribbean ranks 10th of 47 groups on this measure, in the top quarter.
Cause of death, by non-communicable diseases, ages 5-14, female in Latin America & Caribbean, year by year
| Year | % of total female deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 41.0% | — |
| 2010 | 27.6% | -32.5% |
| 2015 | 49.6% | +79.5% |
| 2019 | 51.6% | +4.0% |
| 2020 | 49.3% | -4.3% |
| 2021 | 47.2% | -4.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 41.0% | 41.0% | 41.0% | 1 |
| 2010s | 42.9% | 27.6% | 51.6% | 3 |
| 2020s | 48.2% | 47.2% | 49.3% | 2 |
Countries ranked near Latin America & Caribbean
More health data for Latin America & Caribbean
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 1.78 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.033 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0344 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.0369 units per person (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, female in Latin America & Caribbean?
- Cause of death, by non-communicable diseases, ages 5-14, female in Latin America & Caribbean was 47.2% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, female recorded in Latin America & Caribbean?
- The highest recorded value was 51.6% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, female recorded in Latin America & Caribbean?
- The lowest recorded value was 27.6% in 2010.
- How does Latin America & Caribbean rank for cause of death, by non-communicable diseases, ages 5-14, female?
- Latin America & Caribbean ranks 10th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, female rising or falling in Latin America & Caribbean?
- Over the last ten years it is up 70.6%. The long-run trend across the full record is rising.
- Where does this Latin America & Caribbean data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.